Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
97.88
+0.94 (0.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Revenue
In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth. Zimmer Biomet Holdings had revenue of $2.02B in the quarter ending December 31, 2024, with 4.28% growth.
Revenue (ttm)
$7.68B
Revenue Growth
+3.85%
P/S Ratio
2.59
Revenue / Employee
$451,682
Employees
17,000
Market Cap
19.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZBH News
- 9 days ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results - PRNewsWire
- 16 days ago - PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA - Business Wire
- 18 days ago - Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System - PRNewsWire
- 5 weeks ago - Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Business Wire
- 5 weeks ago - Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PRNewsWire
- 6 weeks ago - Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - PRNewsWire
- 6 weeks ago - Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PRNewsWire
- 7 weeks ago - Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - PRNewsWire